Lifecore Biomedical (LFCR) vs Rocket Pharmaceuticals (RCKT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Lifecore Biomedical (LFCR) has outperformed Rocket Pharmaceuticals (RCKT) over the past year, losing 1.7% versus a loss of 41.2%. Over five years, LFCR leads with a -32.8% price change compared with -92.6% for RCKT. Lifecore Biomedical is the larger company by market cap ($241.8 million vs $239.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFCR | RCKT |
|---|---|---|
| Share price | $6.38 | $2.18 |
| Market cap | $241.84M | $239.31M |
| 1-day change | -0.93% | -7.63% |
| YTD return | -22.00% | -37.89% |
| 1-year return | -1.69% | -41.24% |
| 5-year return | -32.84% | -92.58% |
| EPS (TTM) | $-1.27 | $-0.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $128.87M | $0 |
| Revenue growth (YoY) | +0.47% | — |
| Net income (latest FY) | $-38.72M | $-223.12M |
| Gross margin | 31.27% | — |
| Operating margin | -13.38% | — |
| Net margin | -30.04% | — |
| 52-week high | $8.98 | $5.45 |
| 52-week low | $3.63 | $2.17 |
| Distance from 52-week high | -28.95% | -60.00% |
| Analyst consensus | hold | buy |
| Avg. price target upside | -1.57% | +293.58% |
| Average volume | 330.83K | 1.77M |
| Shares outstanding | 37.91M | 109.77M |
| Employees | 382 | 202 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFCR has outperformed RCKT by 39.5 percentage points over the past year.
About Lifecore Biomedical
LFCR stock →Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
Health Care · Biotechnology: Pharmaceutical Preparations · 382 employees
About Rocket Pharmaceuticals
RCKT stock →Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), which is in phase 1; and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is a form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart, which is in preclinical stage.
Health Care · Biotechnology: Pharmaceutical Preparations · 202 employees
LFCR vs RCKT FAQ
Which is bigger, Lifecore Biomedical or Rocket Pharmaceuticals?
Lifecore Biomedical (LFCR) is larger, with a market capitalization of $241.84M compared with $239.31M for Rocket Pharmaceuticals (RCKT).
Which stock has performed better over the past year, LFCR or RCKT?
LFCR returned -1.69% over the past 12 months, compared with -41.24% for RCKT (price return, excluding dividends). Past performance does not predict future results.
Are Lifecore Biomedical and Rocket Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.